£1.0M
The funding will support the development of the Callavid drug-device combination for threatened miscarriage.
CL
Calla Lily Clinical Care
Developing advanced drug delivery systems for women's healthcare.
London, UK—Founded 2021
£1.0MTotal raised
Calla Lily Clinical Care is a certified B-Corporation developing a novel drug-device combination to improve treatment for threatened miscarriage.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Calla Lily Clinical Care's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
LZ
Lara Zibners
Co-founder and Chair